The effects of sodium glucose co-transporter (SGLT) 2 inhibitors on hematocrit levels: a systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

The effects of sodium glucose co-transporter (SGLT) 2 inhibitors on hematocrit levels: a systematic review and meta-analysis of randomized controlled trials

Published:2021-06 Issue:6 Volume:10 Page:6467-6481
ISSN:2224-5820
Container-title:Annals of Palliative Medicine
language:
Short-container-title:Ann Palliat Med

Author:

Wang Xiaonan,Fu Ran,Liu Hongtao,Ma Yinling,Qiu Xuejia,Dong Zhanjun

Publisher

AME Publishing Company

Subject

Anesthesiology and Pain Medicine,Advanced and Specialised Nursing

Link

https://apm.amegroups.com/article/download/71650/pdf

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07-08

2. Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24‐week, randomized, double‐blind, active‐controlled, phase 3 trial;Journal of Diabetes;2024-04

3. Drug Safety Evaluation of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Comorbid Patients by Review of Systemic Extraglycemic Effects;Diabetes, Metabolic Syndrome and Obesity;2024-03

4. Meta‐analysis of risk of major adverse cardiovascular events in adults with type 2 diabetes treated with bexagliflozin;Diabetes, Obesity and Metabolism;2023-12-27

5. Sodium‐glucose co‐transporter‐2 inhibitor treatment in essential thrombocythemia: Impact on hemoglobin/hematocrit levels and outcomes among 11 consecutive patients;American Journal of Hematology;2023-08-08